Travis Maures

Travis Maures is a prominent scientist and executive in the field of gene editing and CRISPR technology. Here's a summary of his career and accomplishments:

Current Position

Travis Maures is currently the Co-Founder and Chief Scientific Officer (CSO) of EditCo Bio, a newly formed company that spun out from Synthego Corporation in March 2024.13 EditCo Bio focuses on developing and manufacturing highly optimized CRISPR guide RNA designs and edited cells for cell biology and gene therapy research.

Previous Roles at Synthego

Before co-founding EditCo Bio, Maures held several key positions at Synthego Corporation:

• Chief Technology Officer (CTO) from May 2022 to March 20242
• Director of Science Research from October 2018 to July 20222
• Principal Scientist, Functional Biology from June 2018 to July 20222
• Cell Engineering Lead from March 2017 to July 20222

Earlier Career

Prior to joining Synthego, Maures worked as:

• Scientist 2 at BioMarin Pharmaceutical Inc. (October 2014 - March 2017)2
• Stanford Genetics Post Doctoral Fellow at Stanford University (2009 - 2014)2
• Postdoctoral Fellow at the University of Michigan (2008 - 2009)2

Education

Maures holds a Ph.D. in Cellular and Molecular Biology from the University of Michigan, which he obtained between 2003 and 2008. He also earned his BS in Cellular and Molecular Biology from the same institution (1995 - 2000).2

Research Contributions

Throughout his career, Maures has made significant contributions to various fields of biology:

1. At Stanford, he worked on projects related to epigenetic changes and their impact on organismal longevity.2
2. His research at the University of Michigan focused on adapter proteins and their role in cellular functions.2
3. As a graduate student, he studied the molecular mechanisms of neuronal differentiation.2

Expertise and Focus

Maures is recognized for his expertise in:

• CRISPR technology and gene editing
• Cell engineering
• Functional genomics
• Development of research tools and platforms for biological experiments

In his current role at EditCo Bio, Maures is working to advance CRISPR solutions that provide industry-leading gene editing efficacy and reproducibility.3